What is Summit Perfusion Services?
Summit Perfusion Services (SPS) operates as a premier provider of perfusionist expertise, maintaining a distinguished 41-year history of collaboration with elite cardiothoracic surgeons. The company is recognized for its rigorous adherence to evidence-based medicine, having facilitated over 13,000 clinical cases without a single malpractice claim. SPS specializes in critical procedures including open-heart surgery and autotransfusion, while providing essential support to CT ICU, CATH, and EP laboratory environments. By partnering with community-based hospitals to optimize procurement costs for medical disposables and equipment, SPS has been instrumental in elevating partner facilities to Top 100 Heart Hospital status in the United States for three consecutive years.
How much funding has Summit Perfusion Services raised?
Summit Perfusion Services has raised a total of $229K across 2 funding rounds:
Debt
$150K
Debt
$79K
Debt (2020): $150K with participation from PPP
Debt (2021): $79K led by PPP
Key Investors in Summit Perfusion Services
PPP
Public-Private Partnership
What's next for Summit Perfusion Services?
With the infusion of this latest capital, Summit Perfusion Services is strategically positioned to accelerate its market penetration and operational efficiency. The firm intends to utilize these resources to deepen its hospital partnerships, potentially expanding its service model to new geographic territories. By maintaining its focus on board-certified clinical excellence and cost-effective equipment management, SPS is well-equipped to navigate the evolving landscape of cardiovascular care. Future growth will likely center on scaling its proprietary clinical protocols and enhancing its technological infrastructure to support the increasing demand for high-acuity heart care services.
See full Summit Perfusion Services company page
